Marketed as Turalio, pexidartinib is kinase inhibitor that blocks the activity of colony-stimulating factor-1 receptor (CSF-1R). It is used to treat of adults with asymptomatic tenosynovial giant cell tumor (TGST). This evidence concerns the gene CSF1R and tenosynovial giant cell tumor.